Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer

Treatment of triple-negative breast cancer is challenging. Standard adjuvant tretment is considered to be the cobination of anthracycline and taxanes although the role of anthracyclines administered preoperatively  remains controversial. Actually, some studies recommended taxane-only regimens. We re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacinschi, Xenia Elena, Zgura, Anca, Safta, Inga, Anghel, Rodica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685384/
https://www.ncbi.nlm.nih.gov/pubmed/33244272
http://dx.doi.org/10.2147/CMAR.S274104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685384/
https://www.ncbi.nlm.nih.gov/pubmed/33244272
http://dx.doi.org/10.2147/CMAR.S274104

Ejemplares similares